诺卡迪亚cyriacigeorgica 在COPD患者中的感染
Clinical laboratory
|June 11, 2025
概括
由于非特异性症状,对Nocardia cyriacigeorgica肺部感染的准确诊断具有挑战性. 实验室鉴定,包括格拉姆染色和MALDI-TOF MS,对于确认这种机会性病原体至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 由Nocardia spp.引起的肺部感染. 呈现出多样化且往往非特异性的临床和成像发现,增加了误诊的风险.
- 诺卡迪亚cyriacigeorgica是一种有氧的,格拉姆阳性,弱酸快的机会性病原体,其特点是生长缓慢,进一步复杂早期识别.
研究的目的:
- 突出诊断挑战,并强调病因诊断在诺卡迪亚cyriacigeorgica肺部感染中的关键作用.
- 分析一个案例研究,以提高对这种非典型肺部感染的理解和诊断准确度.
主要方法:
- 唾液样本分析包括格拉姆染色和弱酸快染色,以识别格拉姆阳性,分枝和弱酸快细菌.
- 在37°C的有氧条件下,在血上培养唾液,观察缓慢生长的,白色的,干燥的和纹的殖民地.
- 使用MALDI-TOF MS (矩阵辅助激光消化/电离飞行质谱时间) 来识别分离物,并与MS-IVD数据库进行比较.
主要成果:
- 格拉姆染色揭示了许多具有分支和丝状形式的格拉姆阳性细菌;弱酸快染色是阳性的.
- 马尔迪-托夫MS以99.9%的可靠性将隔离物识别为诺卡迪亚cyriacigeorgica.
- 该患者接受了经验性抗生素治疗和支持性护理,但由于多种并发症,没有针对性治疗诺卡迪亚,并专注于急性症状.
结论:
- 准确和及时的病因诊断对于管理Nocardia cyriacigeorgica肺部感染至关重要.
- 临床医生,实验室人员和成像部门之间的密切合作对于诊断和治疗这些非典型感染至关重要.
- 分析实验室诊断方法可以提高对诺卡迪亚肺部感染的理解和检测率.
更多相关视频
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
765
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
378
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Pathogenesis and Clinical Features
242
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
242
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Management Using Bronchodilators and Corticosteroids
185
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
185
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
